USA Vaccine Contract Manufacturing Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Vaccine Contract Manufacturing market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Vaccine Contract Manufacturing market. Detailed analysis of key players, along with key growth strategies adopted by Vaccine Contract Manufacturing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Servier Laboratories (France)

    • Catalent, Inc

    • Cytovance Biologics

    • Mereck KGaA (Germany)

    • Merck KGaA

    • Fujifilm Diosynth Biotechnologies USA, Inc

    • Pfizer Inc (US)

    • Ajinomoto Althea, Inc

    • Lonza

    By Type:

    • Attenuated Vaccine

    • Inactivated Vaccine

    • Subunit vaccines

    • Toxoid Vaccines

    • DNA Vaccines

    By End-User:

    • Pharmaceutical Companies

    • Biotech Companies

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vaccine Contract Manufacturing Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Vaccine Contract Manufacturing Market Size and Growth Rate of Attenuated Vaccine from 2016 to 2027

      • 1.3.2 USA Vaccine Contract Manufacturing Market Size and Growth Rate of Inactivated Vaccine from 2016 to 2027

      • 1.3.3 USA Vaccine Contract Manufacturing Market Size and Growth Rate of Subunit vaccines from 2016 to 2027

      • 1.3.4 USA Vaccine Contract Manufacturing Market Size and Growth Rate of Toxoid Vaccines from 2016 to 2027

      • 1.3.5 USA Vaccine Contract Manufacturing Market Size and Growth Rate of DNA Vaccines from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Vaccine Contract Manufacturing Market Size and Growth Rate of Pharmaceutical Companies from 2016 to 2027

      • 1.4.2 USA Vaccine Contract Manufacturing Market Size and Growth Rate of Biotech Companies from 2016 to 2027

      • 1.4.3 USA Vaccine Contract Manufacturing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Vaccine Contract Manufacturing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Vaccine Contract Manufacturing by Major Types

      • 3.4.1 Market Size and Growth Rate of Attenuated Vaccine

      • 3.4.2 Market Size and Growth Rate of Inactivated Vaccine

      • 3.4.3 Market Size and Growth Rate of Subunit vaccines

      • 3.4.4 Market Size and Growth Rate of Toxoid Vaccines

      • 3.4.5 Market Size and Growth Rate of DNA Vaccines

    4 Segmentation of Vaccine Contract Manufacturing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Vaccine Contract Manufacturing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Vaccine Contract Manufacturing in Pharmaceutical Companies

      • 4.4.2 Market Size and Growth Rate of Vaccine Contract Manufacturing in Biotech Companies

      • 4.4.3 Market Size and Growth Rate of Vaccine Contract Manufacturing in Others

    5 Market Analysis by Regions

    • 5.1 USA Vaccine Contract Manufacturing Production Analysis by Regions

    • 5.2 USA Vaccine Contract Manufacturing Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Vaccine Contract Manufacturing Landscape Analysis

    • 6.1 West USA Vaccine Contract Manufacturing Landscape Analysis by Major Types

    • 6.2 West USA Vaccine Contract Manufacturing Landscape Analysis by Major End-Users

    7 South USA Vaccine Contract Manufacturing Landscape Analysis

    • 7.1 South USA Vaccine Contract Manufacturing Landscape Analysis by Major Types

    • 7.2 South USA Vaccine Contract Manufacturing Landscape Analysis by Major End-Users

    8 Middle West USA Vaccine Contract Manufacturing Landscape Analysis

    • 8.1 Middle West USA Vaccine Contract Manufacturing Landscape Analysis by Major Types

    • 8.2 Middle West USA Vaccine Contract Manufacturing Landscape Analysis by Major End-Users

    9 Northeast USA Vaccine Contract Manufacturing Landscape Analysis

    • 9.1 Northeast USA Vaccine Contract Manufacturing Landscape Analysis by Major Types

    • 9.2 Northeast USA Vaccine Contract Manufacturing Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Servier Laboratories (France)

        • 10.1.1 Servier Laboratories (France) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Catalent, Inc

        • 10.2.1 Catalent, Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Cytovance Biologics

        • 10.3.1 Cytovance Biologics Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Mereck KGaA (Germany)

        • 10.4.1 Mereck KGaA (Germany) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Merck KGaA

        • 10.5.1 Merck KGaA Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Fujifilm Diosynth Biotechnologies USA, Inc

        • 10.6.1 Fujifilm Diosynth Biotechnologies USA, Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Pfizer Inc (US)

        • 10.7.1 Pfizer Inc (US) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Ajinomoto Althea, Inc

        • 10.8.1 Ajinomoto Althea, Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Lonza

        • 10.9.1 Lonza Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of Attenuated Vaccine from 2016 to 2027

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of Inactivated Vaccine from 2016 to 2027

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of Subunit vaccines from 2016 to 2027

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of Toxoid Vaccines from 2016 to 2027

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of DNA Vaccines from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of Pharmaceutical Companies from 2016 to 2027

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of Biotech Companies from 2016 to 2027

    • Figure USA Vaccine Contract Manufacturing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Vaccine Contract Manufacturing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Vaccine Contract Manufacturing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Vaccine Contract Manufacturing

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Vaccine Contract Manufacturing by Different Types from 2016 to 2027

    • Table Consumption Share of Vaccine Contract Manufacturing by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Attenuated Vaccine

    • Figure Market Size and Growth Rate of Inactivated Vaccine

    • Figure Market Size and Growth Rate of Subunit vaccines

    • Figure Market Size and Growth Rate of Toxoid Vaccines

    • Figure Market Size and Growth Rate of DNA Vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Vaccine Contract Manufacturing by Different End-Users from 2016 to 2027

    • Table Consumption Share of Vaccine Contract Manufacturing by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Pharmaceutical Companies

    • Figure Market Size and Growth Rate of Biotech Companies

    • Figure Market Size and Growth Rate of Others

    • Table USA Vaccine Contract Manufacturing Production by Regions

    • Table USA Vaccine Contract Manufacturing Production Share by Regions

    • Figure USA Vaccine Contract Manufacturing Production Share by Regions in 2016

    • Figure USA Vaccine Contract Manufacturing Production Share by Regions in 2021

    • Figure USA Vaccine Contract Manufacturing Production Share by Regions in 2027

    • Table USA Vaccine Contract Manufacturing Consumption by Regions

    • Table USA Vaccine Contract Manufacturing Consumption Share by Regions

    • Figure USA Vaccine Contract Manufacturing Consumption Share by Regions in 2016

    • Figure USA Vaccine Contract Manufacturing Consumption Share by Regions in 2021

    • Figure USA Vaccine Contract Manufacturing Consumption Share by Regions in 2027

    • Table West USA Vaccine Contract Manufacturing Consumption by Types from 2016 to 2027

    • Table West USA Vaccine Contract Manufacturing Consumption Share by Types from 2016 to 2027

    • Figure West USA Vaccine Contract Manufacturing Consumption Share by Types in 2016

    • Figure West USA Vaccine Contract Manufacturing Consumption Share by Types in 2021

    • Figure West USA Vaccine Contract Manufacturing Consumption Share by Types in 2027

    • Table West USA Vaccine Contract Manufacturing Consumption by End-Users from 2016 to 2027

    • Table West USA Vaccine Contract Manufacturing Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2016

    • Figure West USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2021

    • Figure West USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2027

    • Table South USA Vaccine Contract Manufacturing Consumption by Types from 2016 to 2027

    • Table South USA Vaccine Contract Manufacturing Consumption Share by Types from 2016 to 2027

    • Figure South USA Vaccine Contract Manufacturing Consumption Share by Types in 2016

    • Figure South USA Vaccine Contract Manufacturing Consumption Share by Types in 2021

    • Figure South USA Vaccine Contract Manufacturing Consumption Share by Types in 2027

    • Table South USA Vaccine Contract Manufacturing Consumption by End-Users from 2016 to 2027

    • Table South USA Vaccine Contract Manufacturing Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2016

    • Figure South USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2021

    • Figure South USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2027

    • Table Middle West USA Vaccine Contract Manufacturing Consumption by Types from 2016 to 2027

    • Table Middle West USA Vaccine Contract Manufacturing Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Vaccine Contract Manufacturing Consumption Share by Types in 2016

    • Figure Middle West USA Vaccine Contract Manufacturing Consumption Share by Types in 2021

    • Figure Middle West USA Vaccine Contract Manufacturing Consumption Share by Types in 2027

    • Table Middle West USA Vaccine Contract Manufacturing Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Vaccine Contract Manufacturing Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2016

    • Figure Middle West USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2021

    • Figure Middle West USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2027

    • Table Northeast USA Vaccine Contract Manufacturing Consumption by Types from 2016 to 2027

    • Table Northeast USA Vaccine Contract Manufacturing Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Vaccine Contract Manufacturing Consumption Share by Types in 2016

    • Figure Northeast USA Vaccine Contract Manufacturing Consumption Share by Types in 2021

    • Figure Northeast USA Vaccine Contract Manufacturing Consumption Share by Types in 2027

    • Table Northeast USA Vaccine Contract Manufacturing Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Vaccine Contract Manufacturing Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2016

    • Figure Northeast USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2021

    • Figure Northeast USA Vaccine Contract Manufacturing Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Servier Laboratories (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Servier Laboratories (France)

    • Figure Sales and Growth Rate Analysis of Servier Laboratories (France)

    • Figure Revenue and Market Share Analysis of Servier Laboratories (France)

    • Table Product and Service Introduction of Servier Laboratories (France)

    • Table Company Profile and Development Status of Catalent, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalent, Inc

    • Figure Sales and Growth Rate Analysis of Catalent, Inc

    • Figure Revenue and Market Share Analysis of Catalent, Inc

    • Table Product and Service Introduction of Catalent, Inc

    • Table Company Profile and Development Status of Cytovance Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cytovance Biologics

    • Figure Sales and Growth Rate Analysis of Cytovance Biologics

    • Figure Revenue and Market Share Analysis of Cytovance Biologics

    • Table Product and Service Introduction of Cytovance Biologics

    • Table Company Profile and Development Status of Mereck KGaA (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mereck KGaA (Germany)

    • Figure Sales and Growth Rate Analysis of Mereck KGaA (Germany)

    • Figure Revenue and Market Share Analysis of Mereck KGaA (Germany)

    • Table Product and Service Introduction of Mereck KGaA (Germany)

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of Fujifilm Diosynth Biotechnologies USA, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujifilm Diosynth Biotechnologies USA, Inc

    • Figure Sales and Growth Rate Analysis of Fujifilm Diosynth Biotechnologies USA, Inc

    • Figure Revenue and Market Share Analysis of Fujifilm Diosynth Biotechnologies USA, Inc

    • Table Product and Service Introduction of Fujifilm Diosynth Biotechnologies USA, Inc

    • Table Company Profile and Development Status of Pfizer Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc (US)

    • Figure Sales and Growth Rate Analysis of Pfizer Inc (US)

    • Figure Revenue and Market Share Analysis of Pfizer Inc (US)

    • Table Product and Service Introduction of Pfizer Inc (US)

    • Table Company Profile and Development Status of Ajinomoto Althea, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ajinomoto Althea, Inc

    • Figure Sales and Growth Rate Analysis of Ajinomoto Althea, Inc

    • Figure Revenue and Market Share Analysis of Ajinomoto Althea, Inc

    • Table Product and Service Introduction of Ajinomoto Althea, Inc

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.